Needlescopic-assisted Uniportal vs Uniportal VATS (UNeed)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03439696 |
|
Recruitment Status :
Completed
First Posted : February 20, 2018
Last Update Posted : February 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Lung Cancer Lung Cancer Metastatic Bullous Disease Lung Nodule Solitary Pulmonary Mediastinal Tumor | Procedure: Thoracoscopic surgery | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 110 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | Needlescopic-assisted Uniportal VATS Versus Conventional Uniportal VATS. A Randomized Prospective Noninferiority Study |
| Actual Study Start Date : | February 22, 2018 |
| Actual Primary Completion Date : | December 12, 2018 |
| Actual Study Completion Date : | April 30, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Needlescopic-assisted
Thoracoscopic surgery performed with the fashion of single 2.5-3.5 cm intercostal incision and 1-2 additional 2-3 mmm needlescopic ports.
|
Procedure: Thoracoscopic surgery
Video-assisted thoracoscopic surgery for pulmonary or mediastinal lesions. |
|
Active Comparator: Uniportal
Conventional uniportal VATS with single 2.5-3.5 cm intercostal incision
|
Procedure: Thoracoscopic surgery
Video-assisted thoracoscopic surgery for pulmonary or mediastinal lesions. |
- Pain scale POD 3 [ Time Frame: 3 days ]Post-operative day 3 pain scale documented using Visual Analogue Scale (VAS)
- Pain scale POD 5 [ Time Frame: 5 days ]Post-operative day 5 pain scale documented using Visual Analogue Scale (VAS)
- Hospital stay [ Time Frame: 14 days ]Post-operative hospital stay
- Post-operative 3 month neuralgia [ Time Frame: 3 months ]Out patient documented using PainDETECT questionnaire (PD-Q)
- Post-operative 6 month neuralgia [ Time Frame: 6 months ]Out patient documented using PainDETECT questionnaire (PD-Q)
- Cost [ Time Frame: 14 days ]Total hospital cost
- Surgical time [ Time Frame: 1 day ]Time spend in surgery
- Surgical bleeding [ Time Frame: 1 day ]Blood loss during operation
- Opioid using dosage [ Time Frame: 14 days ]Total opioid equivalent dose used during post-operative course
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 90 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Lung or mediastinal disease requiring thoracoscopic surgery
Exclusion Criteria:
Thoracoscopic esophagectomy Decortication for empyema
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03439696
| Taiwan | |
| National Taiwan University Hospital, Hsin-Chu Branch | |
| Taipei, Hsin-Chu County, Taiwan, 30059 | |
| Principal Investigator: | Chiu-kuei Nien | National Taiwan University Hospital Hsinchu Branch |
| Responsible Party: | IRB of NTUH Hsin-Chu Branch, National Taiwan University Hospital Hsin-Chu Branch |
| ClinicalTrials.gov Identifier: | NCT03439696 |
| Other Study ID Numbers: |
106-067-F |
| First Posted: | February 20, 2018 Key Record Dates |
| Last Update Posted: | February 25, 2021 |
| Last Verified: | February 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Thoracoscopy VATS Needlescopy Uniportal |
|
Lung Neoplasms Mediastinal Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases Mediastinal Diseases Thoracic Diseases |

